DV
Dividend Vision

EWTX — Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. (EWTX)

Total return is 47.2% over the past 5.4 years, 63.3 points behind SPY at 110.5%. Its deepest 1-year drawdown was 21.0%.

EWTX is a single-stock equity holding in Edgewise Therapeutics, Inc., a biopharmaceutical company. As a non-diversified stock position rather than a traditional ETF, it carries no dividend distribution and therefore offers no yield profile or regular income to shareholders. This vehicle appeals primarily to investors seeking direct exposure to the therapeutic development activities of Edgewise rather than those pursuing dividend income strategies.

EWTX key facts

Asset type
Stock
Asset class
Equity
Inception date
03/26/2021
Distribution frequency
None
Last close
$44.17
Market cap
$4,797,044,224
Average volume
779900.0
Beta
0.325
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.90